Oncopeptides AB (ONCO) — Net Asset Momentum
Oncopeptides AB (ONCO) recorded a net asset momentum of -208.5% as of December 2025, with net assets of Skr-58.89 Million SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See ONCO days of operational coverage to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Oncopeptides AB Net Asset Momentum (2014–2025)
This chart tracks Oncopeptides AB's year-over-year net asset growth across 12 annual reporting periods from 2014 to 2025. The most recent momentum reading is -208.5%, with net assets of Skr-58.89 Million SEK as of December 2025. Read Oncopeptides AB total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Oncopeptides AB (2014–2025)
The table below shows the complete annual net asset history for Oncopeptides AB from 2014 to 2025, covering 12 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Oncopeptides AB (ONCO) total market value.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Skr-58.89 Million | Skr134.84 Million | Skr193.73 Million | ▼ -208.5% |
| 2024 | Skr54.28 Million | Skr244.19 Million | Skr189.91 Million | ▼ -4.4% |
| 2023 | Skr56.78 Million | Skr238.38 Million | Skr181.60 Million | ▼ -80.7% |
| 2022 | Skr294.29 Million | Skr385.32 Million | Skr91.03 Million | ▲ +39.6% |
| 2021 | Skr210.87 Million | Skr439.38 Million | Skr228.51 Million | ▼ -63.4% |
| 2020 | Skr576.90 Million | Skr946.76 Million | Skr369.86 Million | ▼ -27.6% |
| 2019 | Skr797.01 Million | Skr993.49 Million | Skr196.47 Million | ▲ +152.4% |
| 2018 | Skr315.83 Million | Skr444.53 Million | Skr128.70 Million | ▼ -24.4% |
| 2017 | Skr418.00 Million | Skr479.82 Million | Skr61.82 Million | ▲ +1487.2% |
| 2016 | Skr26.34 Million | Skr55.63 Million | Skr29.30 Million | ▲ +1113.0% |
| 2015 | Skr-2.60 Million | Skr4.40 Million | Skr7.00 Million | ▼ -134.2% |
| 2014 | Skr7.61 Million | Skr13.12 Million | Skr5.52 Million | — |